Literature DB >> 30238388

Alterations in the Serotonin and Dopamine Pathways by Cystathionine Beta Synthase Overexpression in Murine Brain.

J London1, F K Ndiaye2, L C Bui2, B Souchet2, F Daubigney2, C Magnan2, S Luquet2, J Dairou2, N Janel2, C Rouch2.   

Abstract

Cystathionine beta synthase (CBS) is one of the 225 genes on chromosome 21 (HSA 21) that are triplicated in persons with trisomy 21 (Down syndrome). Although most triplicate HSA21 genes have their orthologous genes on murine chromosome 16, the murine ortholog of hCBS is on murine chromosome 17 and thus is not present in the well-studied Ts65Dn mouse model of trisomy 21. Persons with trisomy 21 (T21) present deficits in neurotransmission and exhibit early brain aging that can partially be explained by monoamine neurotransmitter alterations. We used transgenic mice for the hCBS gene, which overexpress the CBS protein in various brain regions, to study if CBS overexpression induces modifications in the monoamine neurotransmitters in the hypothalamus, thalamus, hippocampus, and striatum from transgenic and control female and male mice aged 3-4 months and 11-12 months. Sex, age, and brain area each influenced neurotransmitter levels. Briefly, the serotonin pathway was modified by CBS overexpression in various brain areas in female mice but not in male mice. The dopamine pathway was modified in brain regions according to sex and age. These results may allow us to better understand the role of the transsulfuration pathway and especially CBS overexpression in the metabolism of biogenic amines and the catecholamine catabolism in persons with trisomy 21.

Entities:  

Keywords:  Cystathionine beta synthase (CBS); Monoamine neurotransmitters; Murine brain tissues; Transgenic mice; Trisomy 21 (T21)

Mesh:

Substances:

Year:  2018        PMID: 30238388     DOI: 10.1007/s12035-018-1323-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  85 in total

1.  What dopamine does in the brain.

Authors:  Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

2.  Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome.

Authors:  M T Davisson; C Schmidt; E C Akeson
Journal:  Prog Clin Biol Res       Date:  1990

3.  Blood-serotonin deficiency in Down's syndrome.

Authors:  J B Tu; H Zellweger
Journal:  Lancet       Date:  1965-10-09       Impact factor: 79.321

4.  Homocysteine metabolism in children with Down syndrome: in vitro modulation.

Authors:  M Pogribna; S Melnyk; I Pogribny; A Chango; P Yi; S J James
Journal:  Am J Hum Genet       Date:  2001-06-05       Impact factor: 11.025

5.  Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice.

Authors:  Tao Yu; Chunhong Liu; Pavel Belichenko; Steven J Clapcote; Shaomin Li; Annie Pao; Alexander Kleschevnikov; Allison R Bechard; Suhail Asrar; Rongqing Chen; Ni Fan; Zhenyu Zhou; Zhengping Jia; Chu Chen; John C Roder; Bin Liu; Antonio Baldini; William C Mobley; Y Eugene Yu
Journal:  Brain Res       Date:  2010-10-26       Impact factor: 3.252

6.  Mouse trisomy 16 as an animal model of human trisomy 21 (Down syndrome): production of viable trisomy 16 diploid mouse chimeras.

Authors:  D R Cox; S A Smith; L B Epstein; C J Epstein
Journal:  Dev Biol       Date:  1984-02       Impact factor: 3.582

Review 7.  The neurobiologic consequences of Down syndrome.

Authors:  J T Coyle; M L Oster-Granite; J D Gearhart
Journal:  Brain Res Bull       Date:  1986-06       Impact factor: 4.077

8.  Brain phenotype of transgenic mice overexpressing cystathionine β-synthase.

Authors:  Vinciane Régnier; Jean-Marie Billard; Sapna Gupta; Brigitte Potier; Stéphanie Woerner; Evelyne Paly; Aurélie Ledru; Sabrina David; Sabrina Luilier; Jean-Charles Bizot; Guido Vacano; Jan P Kraus; David Patterson; Warren D Kruger; Jean M Delabar; Jaqueline London
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

Review 9.  Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities.

Authors:  Noemí Rueda; Jesús Flórez; Carmen Martínez-Cué
Journal:  Neural Plast       Date:  2012-05-22       Impact factor: 3.599

10.  A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome.

Authors:  Patricia Lopes Pereira; Laetitia Magnol; Ignasi Sahún; Véronique Brault; Arnaud Duchon; Paola Prandini; Agnès Gruart; Jean-Charles Bizot; Bernadette Chadefaux-Vekemans; Samuel Deutsch; Fabrice Trovero; José María Delgado-García; Stylianos E Antonarakis; Mara Dierssen; Yann Herault
Journal:  Hum Mol Genet       Date:  2009-09-26       Impact factor: 6.150

View more
  2 in total

Review 1.  Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors:  Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-30

2.  Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation and Cellular Bioenergetics in Human Down Syndrome Fibroblasts.

Authors:  Theodora Panagaki; Elisa B Randi; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.